Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
Alimentary Pharmacology & Therapeutics2017Vol. 47(3), pp. 332–345
Citations Over TimeTop 10% of 2017 papers
Quentin Le Bastard, Gabriel A. Al‐Ghalith, Matthieu Grégoire, Guillaume Chapelet, François Javaudin, Éric Dailly, Éric Batard, Dan Knights, Emmanuel Montassier
Abstract
Non-antibiotic prescription drugs have a notable impact on the overall architecture of the intestinal microbiome. Further explorations should seek to define biomarkers of dysbiosis induced by specific drugs, and potentially tailor live biotherapeutics to counter this drug-induced dysbiosis. Many other frequently prescribed drugs should also be investigated to better understand the link between these drugs, the microbiome and health status.
Related Papers
- → Effect of Metformin on Metabolic Improvement and Gut Microbiota(2014)377 cited
- → Quercetin improves gut dysbiosis in antibiotic-treated mice(2020)121 cited
- → Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota(2019)45 cited
- → The Microbiome in HIV-Infected Children(2020)1 cited
- → [Vaginal microbiome: community characteristics and disease intervention].(2021)1 cited